[Liver transplantation for hepatitis B virus cirrhosis].
Sugawara
Yasuhiko
Y
Artificial Organ & Transplantation Division, Department of Surgery, Faculty of Medicine, University of Tokyo.
Makuuchi
Masatoshi
M
D015415:Biomarkers / Q000097:blood; D001926:Brain Death; D003131:Combined Modality Therapy; D004279:DNA, Viral / Q000097:blood; D006509:Hepatitis B; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage; D019259:Lamivudine / Q000008:administration & dosage; D008103:Liver Cirrhosis / Q000517:prevention & control / Q000601:surgery* / Q000821:virology*; D016031:Liver Transplantation; D019520:Living Donors; D011300:Preoperative Care; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage; D055502:Secondary Prevention
D015415:Biomarkers; D004279:DNA, Viral; D017325:Hepatitis B Vaccines; D007136:Immunoglobulins; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; C045213:hepatitis B hyperimmune globulin